Clinical Trials Logo

Ischemic Heart Disease clinical trials

View clinical trials related to Ischemic Heart Disease.

Filter by:

NCT ID: NCT02159235 Completed - Clinical trials for Coronary Artery Disease

Heavy Metals, Angiogenesis Factors and Osteopontin in Coronary Artery Disease (CAD)

Start date: September 2010
Phase: N/A
Study type: Observational

The present study aims is to investigate: 1. whether patients suffering from acute resp. chronic ischemic heart disease show higher levels for cadmium (Cd), lead (Pb) and mercury (Hg) than local and international reference levels suggest; 2. the correlation between severity of coronary artery disease and angiogenic and angiostatic factors (endostatin-ES, angiostatin-AS, VEGF-vascular endothelial growth factor, osteopontin-OPN) The patient population consists of about 270 female and male patients suffering either acute or chronic ischemic heart disease (AIHD:ICD-10 I21; CIHD: ICD-10 I25). 3. whether patients suffering CAD and valve calcification (mitral annulus, aortic valve) show higher levels of endostatin, angiostatin, osteopontin and VEGF compared to patients with CAD but without valve (annulus) calcification The measurement of cadmium (urine), lead, mercury, zinc, endostatin, angiostatin, VEGF (serum) and osteopontin (plasma) in patients with angiographically verified coronary artery disease are in the fore. Furthermore, basic laboratory diagnostics as well as data from coronary angiography and echocardiography will be collected. Additionally, the investigators will inquire heavy metal exposition during life by an interview. Recruitment will be done during the in-patient stay at the General Hospital of Vienna, Medical University of Vienna.

NCT ID: NCT02062424 Completed - Clinical trials for Ischemic Heart Disease

Diet and Prevention of Ischemic Heart Disease: a Translational Approach

DIPI
Start date: February 2014
Phase: N/A
Study type: Interventional

The objective of this study is to test the effect of substitution dietary guidelines that are specifically aimed at the prevention of ischemic heart disease (IHD) on the dietary intake in the general Danish population.

NCT ID: NCT02059512 Completed - Clinical trials for Ischemic Heart Disease

Autologous Bone Marrow Mononuclear Cells in the Combined Treatment of Coronary Heart Disease

TAMIS
Start date: February 2013
Phase: N/A
Study type: Interventional

The purpose of this study evaluate the effect of the method of administration of autologous bone marrow mononuclear cells for the duration of of functioning aorto-coronary bypass grafts in the surgical treatment of coronary heart disease, to assess the degree of effectiveness depending on the method of transplantation (intramyocardial, intracoronary, combined).

NCT ID: NCT02057900 Completed - Clinical trials for Ischemic Heart Disease

Transplantation of Human Embryonic Stem Cell-derived Progenitors in Severe Heart Failure

ESCORT
Start date: May 27, 2013
Phase: Phase 1
Study type: Interventional

The purpose of the study is to assess the feasibility and safety of a transplantation of cardiac-committed progenitor cells derived from human embryonic stem cells in patients with severe heart failure.

NCT ID: NCT02003456 Completed - Clinical trials for Myocardial Infarction

Initial Human Validation of Simultaneous Dual-Tracer Cardiac PET Imaging

Start date: December 2013
Phase: Early Phase 1
Study type: Interventional

Positron emission tomography (PET) scans can be used to evaluate whether parts of the heart muscle are alive but receiving inadequate blood supply. This study involves the use of two radiotracers that will measure whether heart muscle cell are alive and quantify the blood supply to the heart muscle.

NCT ID: NCT01946724 Completed - Clinical trials for Ischemic Heart Disease

In-hospital and Long-term Outcomes for Percutaneous Chronic Total Coronary Occlusion Revascularization in a High-volume, Multi-operator Program

Perspective
Start date: August 2013
Phase:
Study type: Observational

The purpose of this study is to study whether percutaneous chronic total occlusion (CTO) revascularization, by the use of Percutaneous Coronary Intervention (PCI), stenting, guidewire, and catheter, improves a patient's quality of life and their left ventricular function, reduces angina severity, and improves long-term survival.

NCT ID: NCT01912690 Completed - Clinical trials for Congestive Heart Failure

The Influence of Different Training Regimens on Electrical Stability Following Myocardial Infarction

Start date: July 2013
Phase: N/A
Study type: Interventional

The hypothesis of the study is that aerobic conditioning following acute heart attack will improve autonomic function and electrical stability of the heart.

NCT ID: NCT01912248 Completed - Heart Failure Clinical Trials

Acute Effect of Strength Training on Blood Pressure in Cardiac Patients

Start date: July 2013
Phase: N/A
Study type: Observational

Moderate and heavy strength training exercise and the acute blood pressure rise in cardiac patient, how high?

NCT ID: NCT01878370 Completed - Hypertension Clinical Trials

Audit and Feedback for Primary Care: a Cluster-randomized Trial

Start date: June 2013
Phase: N/A
Study type: Interventional

In a previous study, the investigators delivered graphs to family physicians that outlined the proportion of patients with a history of diabetes or heart disease achieving evidence-based quality targets derived from guideline recommendations. A qualitative evaluation found that participating family physicians did not act upon the feedback for two main reasons. First, they felt that targets recommended in guidelines often did not apply for particular patients. Second, they complained that had difficulty using the feedback reports that only provided aggregate level data for clinical action. In this cluster-randomized trial, the investigators test two approaches to conducting audit and feedback that aims to address these issues. The investigators hypothesize that feedback identifying a small number of patients at high-risk for cardiovascular events requiring action will more effectively lead to changes in clinical behavior than feedback identifying all patients not reaching optimal care targets.

NCT ID: NCT01877616 Completed - Stroke Clinical Trials

Sleep Disorders and Their Cardiovascular Correlates in Atahualpa.

Start date: June 2013
Phase: N/A
Study type: Interventional

Little is known on the prevalence of sleep disorders and their role in the increased prevalence of cardiovascular diseases in the developing world. We To assess the prevalence of major sleep disorders in a rural South American population, and to determine whether these conditions are associated with a poor cardiovascular health or with the occurrence of stroke or ischemic heart disease. This is a three-phase, population-based, door-to-door survey in Atahualpa. During phase I, all residents aged ≥40 years will be screened with validated Spanish versions of five questionnaires to evaluate major sleep disorders. In phase II, neurologists will examine persons suspected of having a sleep disorder and a random sample of negative individuals to assess the prevalence of these conditions and to validate the accuracy of questionnaires. In phase III, patients with a confirmed sleep disorder will undergo nocturnal polysomnography for achieving a more specific diagnosis. The occurrence of sleep disorders will be correlated with the cardiovascular health of the population as well as with the presence of stroke and ischemic heart disease. This epidemiological study may prove cost-effective in improving sleep conditions of people living in rural areas of developing countries, and may be used as a model for the evaluation of sleep disorders and their cardiovascular correlates in these populations.